ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Initial data from 15 patients with relapsed/refractory marginal zone lymphoma show 13 patients achieved a complete response and one patient achieved a partial response with ZYNLONTA® All patients.
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
LAUSANNE, Switzerland, May 06, 2024 ADC Therapeutics SA today announced that it has agreed to sell, by way of an underwritten offering, 13,411,912 of its common shares at a price of $4.900 per.
ADC Therapeutics SA: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.